Study reveals that COVID-19 vaccines moderately reduce the risk of long COVID in children, with higher effectiveness observed in adolescents compared to younger children.
Secretive Treeline Biosciences discloses $421M financing in filing
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS